- kalina
- 01 Nov, 2002
- New York City
President Bush's recent proposal to speed up introduction of generic drugs into the market and thus slash costs for consumers, has pushed generic drug stocks into the spotlight.
- iliana
- 25 Oct, 2002
- New York City
Though currently they seem overpriced, dollar-store stocks possess some of the solid fundamentals the market is looking for today. And, their prospects have never been brighter.
- vanya
- 24 Oct, 2002
- New York City
With private financiers shying away from untried waters, funds are hard to come by even for worthy start-ups. However, all
- vicky
- 23 Oct, 2002
- New York City
Analog Devices looks poised to beat market expectations in Q4, but the stock
- kalina
- 21 Oct, 2002
- New York City
Despite the many concerns associated with big pharmaceuticals, the sector seems to be in good shape for gains in the near future as the market enters its strongest period.
- iliana
- 11 Oct, 2002
- New York City
Based on current earnings estimates the Quiksilver stock seems valued quite fairly at the moment. But rising sales and growth opportunities make the company worthy of a closer look
- kalina
- 10 Oct, 2002
- New York City
For the majority of market sectors, September was a very harsh month. The biotech sector too wasn
- vanya
- 08 Oct, 2002
- New York City
A weak economy, tumbling stock markets and increased scrutiny on Wall Street took a toll on the IPO market in the third quarter. Is there light at the end of this dark tunnel?
- vanya
- 01 Oct, 2002
- New York City
Search engines have not only become a widely used daily tool of Internet surfers but also represent big business opportunities. A prime example is, paid search-engine listing.
- kalina
- 30 Sep, 2002
- New York City
Having just achieved its first profitable quarter, and supported by rising sales and launch of a new drug, biotech company Gilead Sciences is poised to attain more success ahead.
- iliana
- 27 Sep, 2002
- New York City
Organic food chains Whole Foods and Wild Oats offer consumers products that ensure a healthier way of life. Currently overpriced, their stocks are likely to be long-term favorites
- vanya
- 18 Sep, 2002
- New York City
Although gloom hangs over the wireless industry, VCs are still finding some diamonds in the rough
- kalina
- 17 Sep, 2002
- New York City
Important symposiums and regulatory reviews of drugs this September are likely to spark investor interest in biotech stocks and prompt a rally in case of positive developments.
- vicky
- 16 Sep, 2002
- New York City
In the current depressed market scenario, investors can easily avoid risk by putting money in the bank - but diversified financial stocks appear to be a good, flexible alternative
- iliana
- 12 Sep, 2002
- New York City
Supported by future growth potential and its current trimmed, attractive valuations, the stock of teen apparel retailer, Wet Seal, seems to be in fine shape to woo investors